Stock News

Boston Scientific Sees More Revenue Doom and Gloom in Second Quarter
The Daily Biotech Pulse: Novartis Scraps Deal To Sell Sandoz Assets, Nevro Pre-Announces Q1 Shortfall, Affimed Granted Orphan Drug Designation
Boston Scientific sees Q1 revenue flat to up slightly as coronavirus delays elective procedures
Boston Scientific Provides Update on COVID-19 Impact and Response Efforts
Boston Scientific withdraws financial guidance given business disruptions related to COVID-19 pandemic
Top Health Care Stocks for April 2020
Hedge Funds Flocked Into Boston Scientific Corporation (BSX) At The Wrong Time

As seen on...